Menopause
From the Journals
Don’t choose hormones to protect postmenopausal women
The USPSTF has issued a recommendation against using estrogen or estrogen plus progestin to prevent chronic conditions in postmenopausal women.
Expert Commentary
How to assess a patient for a bisphosphonate drug holiday
Dr. McClung also discusses long-term denosumab therapy
Clinical Review
2017 Update on bone health
Postmenopausal bone loss places a large disease burden on older women. In this article: latest ACP treatment guidelines, news on fracture risk...
Expert Commentary
Hypoactive sexual desire disorder: The ideal patient for treatment with flibanserin
Gynecologic Oncology Consult
Strategies to evaluate postmenopausal bleeding
Pros and cons of blind and targeted sampling.
Expert Commentary
Did long-term follow-up of WHI participants reveal any mortality increase among women who received HT?
No. Cumulative 18-year follow-up data from 2 randomized WHI clinical trials between 1993 and 1998 (followed through December 2014...
Conference Coverage
Beyond the Kegel: the who, why, and how of pelvic floor PT
PT referrals are an option for pelvic floor dysfunction after menopause.
Conference Coverage
Morphology index guides adnexal mass workup in postmenopausal women
The first international consensus report on adnexal masses notes the significantly higher surgery rates in the United States, compared with Europe...
From the Journals
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?
Expert questions whether current guidance favoring total thyroidectomy goes too far.
Expert Commentary
Clinical pearls from NAMS 2017
Take the fear out of hormone therapy, says Dr. Kaunitz. Listen to this pearl and other meeting takeaways from the Program Chair of the 2017 North...
Conference Coverage
VIDEO: Expert roundtable on hormone therapy
Some of the experts who crafted the 2017 NAMS position statement on hormone therapy discuss the new messages for clinicians and the evidence to...